Loading insider details...
Latest Form 4 (Oct 9, 2026): Disposition to Issuer of 44,943 BLFS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 9, 2026 | BIOLIFE SOLUTIONS INC (BLFS) | Disposition to Issuer | 44,943 | n/a |
| Feb 26, 2026 | BIOLIFE SOLUTIONS INC (BLFS) | Grant/Award | 8,170 | n/a |
| Jun 4, 2025 | CERUS CORP (CERS) | Grant/Award | 60,000 | n/a |
| Mar 20, 2025 | BIOLIFE SOLUTIONS INC (BLFS) | Grant/Award | 6,876 | n/a |
| Feb 5, 2025 | Allogene Therapeutics, Inc. (ALLO) | Sale | 14,746 | $25.2K |
| Jun 6, 2024 | CERUS CORP (CERS) | Grant/Award | 40,000 | $200.0K |
| Apr 24, 2024 | Allogene Therapeutics, Inc. (ALLO) | Tax Withholding | 17,360 | $60.2K |
| Mar 13, 2024 | BIOLIFE SOLUTIONS INC (BLFS) | Grant/Award | 11,264 | n/a |
| Jan 31, 2024 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 96,600 | n/a |
| Nov 3, 2023 | BIOLIFE SOLUTIONS INC (BLFS) | Grant/Award | 495 | n/a |